Medical News Summary: New BPH drug has fewer side effects


About: New BPH drug has fewer side effects
Date: 22 November 2004
Source: The Financial Express
Medical News Summary (summary of medical news story as reported by The Financial Express): A pharmaceuticals company has launched a once daily medication called Foltral (alfuzosin) to treat benign prostatic hyperplasia (BPH) to a urological disorder. The medication is well tolerated and has a lower incidence of postural hypotension, syncope, erectile dysfunction and ejaculatory disorders compared to the alternative alpha-blockers. BPH is very common and affects more than half of men over 60 and about 80% of those over 80. Untreated BPH can lead to urinary tract infections, bladder and kidney damage, bladder stones and incontinence.
Related Disease Topics: Benign prostatic hyperplasia, Urological disorder, Postural hypotension, Syncope, Erectile dysfunction, Ejaculatory disorder, Urinary tract infection, Bladder and kidney damage, Bladder stones (type of Urinary stones), Incontinence
Related Symptom Topics: Enlarged prostate gland

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

Medical Tools & Articles:

Next articles:

Medical Articles:
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise